
February 4, 2020
Study finds blood test accurately tracks HPV-linked head and neck cancer
An experimental blood test accurately detected HPV-linked head and neck cancer recurrence and confirmed when patients remained cancer-free.
February 4, 2020
An experimental blood test accurately detected HPV-linked head and neck cancer recurrence and confirmed when patients remained cancer-free.
January 16, 2020
Yuliya Pylayeva-Gupta, PhD, and Gaorav Gupta, MD, PhD, use their natural curiosity and drive to tackle cancer through their research at UNC Lineberger.
November 5, 2019
A University of North Carolina Lineberger Comprehensive Cancer Center-led research team has used genetic insights about head and neck cancers linked to HPV, or human papillomavirus, to improve laboratory tools for studying the disease. Leveraging their discovery that different subtypes of HPV-linked oropharyngeal squamous cell carcinoma exist based on the expression levels of two different …
August 26, 2019
November 20, 2018
November 2, 2018
The President’s Cancer Panel report raises concerns about the government’s Healthy People 2020 goal of 80 percent of age-eligible adolescents being vaccinated against HPV infection.
October 23, 2018
UNC Lineberger's Bhishamjit S. Chera, MD, will present preliminary findings at the 60th Annual Meeting of the American Society for Radiation Oncology on Tuesday from a study that evaluated a blood test for HPV-linked oropharyngeal squamous cell carcinoma, which is a cancer of the back of the throat. The findings demonstrated the test could be an effective and less costly alternative for monitoring for cancer recurrence after radiation treatment.
June 7, 2018
The directors of the 70 National Cancer Institute-designated cancer centers, including UNC Lineberger Comprehensive Cancer Center, say a national effort is needed to improve the rate of HPV vaccination and screening in the United States.
July 25, 2017
A study led by UNC Lineberger's Jennifer Smith, PhD, professor of epidemiology at the UNC Gillings School of Global Public Health, found that among a group of 429 women who did not undergo routine cervical cancer screenings, two-thirds used and returned an in-home self-test, and 15 percent tested positive for human papillomavirus.
October 25, 2016
Andrew Olshan, PhD, and colleagues reported in Nature Genetics that immune system-related genetic variation may provide new insight into the mechanisms of protection against human papillomavirus-associated head and neck cancer.